Literature DB >> 18787412

Fibroblasts act as co-conspirators for chemotherapy resistance.

Derek C Radisky1.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18787412     DOI: 10.4161/cbt.7.9.6850

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  5 in total

1.  Hsp90 as a gatekeeper of tumor angiogenesis: clinical promise and potential pitfalls.

Authors:  J E Bohonowych; U Gopal; J S Isaacs
Journal:  J Oncol       Date:  2010-06-24       Impact factor: 4.375

2.  Cancer Associated Fibroblast-Derived Hepatocyte Growth Factor Inhibits the Paclitaxel-Induced Apoptosis of Lung Cancer A549 Cells by Up-Regulating the PI3K/Akt and GRP78 Signaling on a Microfluidic Platform.

Authors:  Li Ying; Ziwei Zhu; Zhiyun Xu; Tianrui He; Encheng Li; Zhe Guo; Fen Liu; Chunmeng Jiang; Qi Wang
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

3.  Cancer-associated fibroblasts promote non-small cell lung cancer cell invasion by upregulation of glucose-regulated protein 78 (GRP78) expression in an integrated bionic microfluidic device.

Authors:  Ting Yu; Zhe Guo; Hui Fan; Jing Song; Yuanbin Liu; Zhancheng Gao; Qi Wang
Journal:  Oncotarget       Date:  2016-05-03

Review 4.  Role of cancer-associated fibroblasts in the resistance to antitumor therapy, and their potential therapeutic mechanisms in non-small cell lung cancer.

Authors:  Congcong Chen; Jia Hou; Sizhe Yu; Wenyuan Li; Xiao Wang; Hong Sun; Tianjie Qin; Francois X Claret; Hui Guo; Zhiyan Liu
Journal:  Oncol Lett       Date:  2021-03-23       Impact factor: 2.967

5.  Tumor-associated fibroblast-conditioned medium induces CDDP resistance in HNSCC cells.

Authors:  Teresa Bernadette Steinbichler; Veronika Metzler; Christian Pritz; Herbert Riechelmann; Jozsef Dudas
Journal:  Oncotarget       Date:  2016-01-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.